Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.
Induction of interleukin-6 during human immunodeficiency virus infection.
Blood. 1990 Dec 1;76(11):2303-10. Unique Identifier : AIDSLINE MED/91077439 Birx DL; Redfield RR; Tencer K; Fowler A; Burke DS; Tosato G; Division of Retrovirology, Walter Reed Army Institute of; Research, Washington DC.
Abstract:
Interleukin-6 (IL-6), a multifunctional cytokine produced in monocytes, fibroblasts, and other cell types, is induced by a variety of stimuli, including bacteria, viruses, and other cytokines. When normal monocyte cultures were exposed to a monocytotropic strain of human immunodeficiency virus (HIV), HTLV-IIIBa-L, significant levels of IL-6 bioactivity were detected in the culture supernatants after 12 to 43 days of incubation, at a time when there was associated evidence of HIV production. Similarly, when normal monocyte cultures were cocultured with peripheral blood mononuclear cells from HIV-infected individuals, HIV replication in these cultures was associated with production of IL-6. In further studies, we determined that mean serum levels of IL-6 bioactivity were abnormally elevated in HIV-seropositive individuals with stage 1/2 infection (25.2 x/divided by 1.8 U/mL) and stage 3/4 infection (46.1 x/divided by 1.7 U/mL) when compared with normals (1.6 x/divided by 1.2 U/mL). In contrast mean serum IL-6 levels were not different from normal in stage 5/6 infection (2.7 x/divided by 1.6 U/mL). A selected group of 12 HIV-seropositive individuals (stages 1, 2, and 3) who harbored HIV capable of replicating in T cells but not in monocyte cultures had a mean serum IL-6 level of 5.3 U/mL (x/divided by 1.5), a value significantly lower (P less than .004) than that measured in control HIV-seropositive individuals infected with monocytropic HIV (39 x/divided by 1.9 U/mL). In addition, serum IL-6 levels in HIV-seropositive individuals (stages 1 through 6) correlated directly with serum immunoglobulin G (IgG) levels (R = .74, P less than .001). Monocytes but not T cells are capable of a high level IL-6 production in vitro, and monocyte-derived IL-6 stimulates Ig production in activated B cells. Thus, HIV-seropositive individuals who often are infected with monocytotropic HIV and often display abnormally elevated serum IgG levels may exhibit these abnormalities as a consequence of abnormally elevated IL-6 levels induced by HIV.
Keywords: Cells, Cultured Human HIV/ISOLATION & PURIF/*PHYSIOLOGY HIV Infections/*METABOLISM/MICROBIOLOGY HIV Seropositivity/BLOOD IgG/METABOLISM Interleukin-2/PHARMACOLOGY Interleukin-6/*BIOSYNTHESIS/BLOOD Leukocytes, Mononuclear/METABOLISM/MICROBIOLOGY Monocytes/METABOLISM/MICROBIOLOGY Phytohemagglutinins/PHARMACOLOGY Support, U.S. Gov't, Non-P.H.S. T-Lymphocytes/METABOLISM/MICROBIOLOGY Virus Replication JOURNAL ARTICLE 910430
M9140659
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.
